CMS approves rule to encourage value-based drug pricing

CMS approved its plan to make it easier for private insurers, state Medicaid programs and prescription drug manufacturers to create value-based payment arrangements tied to clinical outcomes.



from Section Page News - Modern Healthcare https://ift.tt/38plM9x
via IFTTT

Post a Comment

0 Comments